Invitae Completes Selected Assets Sale of its Next Generatio

/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it has completed a transaction with Integrated DNA Technologies,...

Related Keywords

Ken Knight , Hoki Luk , Invitae Corporation , Technologies Inc , Research Use Only , Invitae Personalized Cancer Monitoring , Next Generation Sequencing , Anchored Multiplex , Private Securities Litigation Reform Act , Quarterly Report ,